MITO-6: Capecitabine in Platinum Resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Capecitabine
Related studies linked through entity extraction aliases.
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2/PHASE3
Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine
- Status
- TERMINATED
- Phase
- PHASE3
AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE1
Capecitabine and Oxaliplatin in Adenocarcinoma of the Small Bowel and Ampulla of Vater
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Stomach Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Etoposide, Oxaliplatin and Capecitabine in Advanced Hepatocellular Carcinoma (HCC)
- Status
- TERMINATED
- Phase
- PHASE2
Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
1stline Study Capecitabine Administered on Continuous Way Plus Oxaliplatin&Bevacizumab Every 2weeks in Metastatic CCR.
- Status
- COMPLETED
- Phase
- PHASE2
The DISTAL-2 Study: Docetaxel Alone or in Combination in Second-line Treatment of Advanced Non Small-Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE3